Literature DB >> 24810774

What does the electroencephalogram tell us about the mechanisms of action of ECT in major depressive disorders?

Faranak Farzan1, Nash N Boutros, Daniel M Blumberger, Zafiris J Daskalakis.   

Abstract

Electroconvulsive therapy (ECT) remains to be one of the most effective treatment options in treatment-resistant major depressive disorder (MDD). From the early days, researchers have embarked on extracting information from electroencephalography (EEG) recordings before, during, and after ECT to identify neurophysiological targets of ECT and discover EEG predictors of response to ECT in patients with MDD. In this article, we provide an overview of visually detected and quantitative EEG features that could help in furthering our understanding of the mechanisms of action of ECT in MDD. We further discuss the EEG findings in the context of postulated hypotheses of ECT therapeutic pathways. We introduce an alternative and unifying hypothesis suggesting that ECT may exert its therapeutic efficacy through resetting the aberrant functional connectivity and promoting the generation of new and healthy connections in brain regions implicated in MDD pathophysiology, a mechanism that may be in part mediated by the ECT-induced activation of inhibitory and neuroplasticity mechanisms. We further discuss the added value of EEG markers in the larger context of ECT research and as complementary to neuroimaging and genetic markers. We conclude by drawing attention to the need for longitudinal studies in large cohort of patients and the need for standardization and validation of EEG algorithms of functional connectivity across studies to facilitate the translation of EEG correlates of ECT response in routine clinical practice.

Entities:  

Mesh:

Year:  2014        PMID: 24810774     DOI: 10.1097/YCT.0000000000000144

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  14 in total

1.  A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants.

Authors:  Okko Alitalo; Roosa Saarreharju; Ioline D Henter; Carlos A Zarate; Samuel Kohtala; Tomi Rantamäki
Journal:  Prog Neurobiol       Date:  2021-08-14       Impact factor: 10.885

Review 2.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2022-02

3.  Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression.

Authors:  Erin M van Buel; Hannes Sigrist; Erich Seifritz; Lianne Fikse; Fokko J Bosker; Robert A Schoevers; Hans C Klein; Christopher R Pryce; Ulrich Lm Eisel
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

4.  Anterior cingulate gamma-aminobutyric acid concentrations and electroconvulsive therapy.

Authors:  Vera J Erchinger; Jeremy Miller; Thomas Jones; Ute Kessler; Juan Bustillo; Jan Haavik; Jonathan Petrillo; Gregory Ziomek; Åsa Hammar; Ketil J Oedegaard; Vince D Calhoun; Shawn M McClintock; Lars Ersland; Leif Oltedal; Christopher C Abbott
Journal:  Brain Behav       Date:  2020-09-17       Impact factor: 2.708

Review 5.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2021-06-09

6.  Using EEG to Predict Clinical Response to Electroconvulsive Therapy in Patients With Major Depression: A Comprehensive Review.

Authors:  Louis Simon; Martin Blay; Filipe Galvao; Jerome Brunelin
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

7.  Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression.

Authors:  Serkan Zincir; Pelin Öztürk; Ali Emrah Bilgen; Filiz İzci; Cihad Yükselir
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-15       Impact factor: 2.570

8.  Cognitive and Neurophysiological Recovery Following Electroconvulsive Therapy: A Study Protocol.

Authors:  Ben J A Palanca; Hannah R Maybrier; Angela M Mickle; Nuri B Farber; R Edward Hogan; Emma R Trammel; J Wylie Spencer; Donald D Bohnenkamp; Troy S Wildes; ShiNung Ching; Eric Lenze; Mathias Basner; Max B Kelz; Michael S Avidan
Journal:  Front Psychiatry       Date:  2018-05-14       Impact factor: 4.157

9.  Selective modulation of brain network dynamics by seizure therapy in treatment-resistant depression.

Authors:  Sravya Atluri; Willy Wong; Sylvain Moreno; Daniel M Blumberger; Zafiris J Daskalakis; Faranak Farzan
Journal:  Neuroimage Clin       Date:  2018-10-17       Impact factor: 4.881

10.  Modulation of functional network properties in major depressive disorder following electroconvulsive therapy (ECT): a resting-state EEG analysis.

Authors:  Aron T Hill; Itay Hadas; Reza Zomorrodi; Daphne Voineskos; Faranak Farzan; Paul B Fitzgerald; Daniel M Blumberger; Zafiris J Daskalakis
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.